Talkspace Debt to Equity Ratio 2020-2025 | TALK
Current and historical debt to equity ratio values for Talkspace (TALK) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Talkspace debt/equity for the three months ending September 30, 2025 was 0.00.
| Talkspace Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-09-30 | $0.02B | $0.11B | 0.18 |
| 2025-06-30 | $0.02B | $0.11B | 0.18 |
| 2025-03-31 | $0.02B | $0.11B | 0.18 |
| 2024-12-31 | $0.02B | $0.12B | 0.18 |
| 2024-09-30 | $0.02B | $0.12B | 0.18 |
| 2024-06-30 | $0.02B | $0.11B | 0.17 |
| 2024-03-31 | $0.02B | $0.12B | 0.16 |
| 2023-12-31 | $0.02B | $0.12B | 0.20 |
| 2023-09-30 | $0.02B | $0.12B | 0.19 |
| 2023-06-30 | $0.02B | $0.12B | 0.17 |
| 2023-03-31 | $0.02B | $0.12B | 0.19 |
| 2022-12-31 | $0.03B | $0.13B | 0.23 |
| 2022-09-30 | $0.03B | $0.14B | 0.23 |
| 2022-06-30 | $0.03B | $0.16B | 0.19 |
| 2022-03-31 | $0.03B | $0.18B | 0.17 |
| 2021-12-31 | $0.03B | $0.19B | 0.16 |
| 2021-09-30 | $0.04B | $0.21B | 0.20 |
| 2021-06-30 | $0.07B | $0.20B | 0.34 |
| 2021-03-31 | $0.41B | $0.01B | 81.96 |
| 2020-12-31 | $0.13B | $-0.10B | -1.33 |
| 2020-09-30 | $0.41B | $0.01B | 82.11 |
| 2020-06-30 | $0.41B | $0.01B | 82.14 |
| 2020-03-31 | $0.00B | $0.00B | 0.00 |
| 2019-12-31 | $0.00B | $0.00B | 0.00 |
| 2019-09-30 | $0.00B | $0.00B | 0.00 |
| 2019-06-30 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.562B | $0.188B |
| Talkspace Inc. is a virtual behavioral healthcare company. It delivered services through an easy-to-use and fully encrypted web and mobile platform, consistent with HIPAA and other state regulatory requirements. The company offers treatment options for almost every need. Talkspace Inc., formerly known as Hudson Executive Investment Corp., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.674B | 59.39 |
| Tempus AI (TEM) | United States | $12.352B | 0.00 |
| Doximity (DOCS) | United States | $9.545B | 39.50 |
| Hims & Hers Health (HIMS) | United States | $8.883B | 72.26 |
| IRhythm Technologies (IRTC) | United States | $5.771B | 0.00 |
| Hinge Health (HNGE) | United States | $3.320B | 0.00 |
| Heartflow (HTFL) | United States | $2.981B | 0.00 |
| Privia Health (PRVA) | United States | $2.979B | 186.31 |
| Inspire Medical Systems (INSP) | United States | $2.642B | 43.71 |
| 10x Genomics (TXG) | United States | $2.078B | 0.00 |
| Enovis (ENOV) | United States | $1.787B | 9.38 |
| Omnicell (OMCL) | United States | $1.654B | 33.82 |
| Azenta (AZTA) | United States | $1.410B | 61.54 |
| Phreesia (PHR) | United States | $1.387B | 0.00 |
| Schrodinger (SDGR) | United States | $1.323B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.286B | 0.00 |
| Claritev (CTEV) | United States | $0.966B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.899B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.571B | 0.00 |
| Veradigm (MDRX) | United States | $0.536B | 0.00 |
| Evolent Health (EVH) | United States | $0.523B | 0.00 |
| Standard BioTools (LAB) | United States | $0.454B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.369B | 0.00 |
| Carlsmed (CARL) | United States | $0.328B | 0.00 |
| TruBridge (TBRG) | United States | $0.303B | 13.93 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.292B | 0.00 |
| CapsoVision (CV) | United States | $0.259B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.243B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.201B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.195B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.175B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.174B | 0.00 |
| CareCloud (CCLD) | United States | $0.136B | 7.45 |
| EUDA Health Holdings (EUDA) | Singapore | $0.110B | 0.00 |
| Outset Medical (OM) | United States | $0.101B | 0.00 |
| Pulmonx (LUNG) | United States | $0.080B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.076B | 0.00 |
| American Well (AMWL) | United States | $0.066B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.055B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.038B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.032B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.028B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.021B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.015B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Movano (MOVE) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |